A survey on hematology-oncology pediatric AIEOP centres: The challenge of posterior reversible encephalopathy syndrome.
Daniele ZamaPietro GasperiniMassimo BergerMariagrazia PetrisMaria D De PasqualeSimone CesaroMaria E GuerzoniElena MastrodicasaFrancesca SavinaOttavio ZiinoValentina KirenPaola MuggeoRosa M MuraFraia MelchiondaGiulio A Zanazzonull nullPublished in: European journal of haematology (2017)
This study demonstrates that PRES is a common neurological complication and occurring preferentially in course of induction treatment of some hematologic malignancies, as ALL and after HSCT. It also highlights great clinical differences in the management and outcome in patients with PRES occurring after chemotherapy or after HSCT.